Granules India Ltd has completed inspection formalities for USFDA inspections in its Vizag plant in Andhra Pradesh. It has not received any observation, while its […]
Biocon has acquired a manufacturing unit of Acacia Lifesciences in Vizag for an undisclosed amount. The company has acquired business assets of the pharmaceutical manufacturing […]
Granules India has received approval from the USFDA to market generic Ibuprofen tablets in US markets. The Hyderabad-based company said US FDA has approved its […]
Aurobindo Pharma has received USFDA approval for the drug Tramadol Hydrochloride extended-release tablets, which is used for treating pain for extended period in adults. The […]
Aurobindo Pharma has approval from USFDA for the generic drug Telmisartan used in treatment for hypertension. The company has received approval to manufacture and market […]
Lupin has received final approval from USFDA for its Omeprazole delayed-release capsules 40 mg which is market equivalent of AstraZeneca Prilosec delayed-release capsules 40mg. The […]
Aurobindo Pharma has received the final approval from USFDA for Raloxifene Hydrochloride tablets, which is bio-equivalent and therapeutic equivalent to the reference listed drug product […]
Ajanta Pharma has received final approval for its three ANDAs (Abbreviated New Drug Application) by USFDA for Montelukast tablets in the strength of 10 mg, […]
Sun Pharmaceutical Industries has received approval from USFDA for its new drug used for acne treatment XiminoTM extended-release capsules in strengths of 45 mg, 90 […]
Dr Reddy’s Laboratories has launched generic Pramipexole dihydrochloride extended-release tablets for treatment of Parkinson’s disease in the US market. The company has launched the tablets […]
Copyright © 2024 | WordPress Theme by MH Themes